IGWM
JAZZ icon

ICA Group Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

ICA Group Wealth Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$107 Hold
1
– – ﹤0.01% 786
2024
Q1 		$120 Hold
1
– – ﹤0.01% 1330
2023
Q4 		$123 Buy
+1
New +$125 ﹤0.01% 1322
2023
Q3 		– Sell
-1
Closed -$124 – 723
2023
Q2 		$124 Hold
1
– – ﹤0.01% 1310
2023
Q1 		$146 Hold
1
– – ﹤0.01% 1245
2022
Q4 		$157 Buy
+1
New +$147 ﹤0.01% 1284

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return

ICA Group Wealth Management's JAZZ Position: Q2 2024 in Review

ICA Group Wealth Management held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2024 at 1 share worth $107. The position accounts for ﹤0.01% of the portfolio, ranked #786.

ICA Group Wealth Management first reported a position in JAZZ in Q4 2022 and has held it in 6 quarters since. The position peaked at $157 in Q4 2022. 455 funds tracked by Wall St. Rank hold JAZZ as of Q2 2024.

  • ICA Group Wealth Management held 1 share of Jazz Pharmaceuticals worth $107 as of Q2 2024.
  • ICA Group Wealth Management left its Jazz Pharmaceuticals share count unchanged in Q2 2024.
  • Jazz Pharmaceuticals made up ﹤0.01% of ICA Group Wealth Management's portfolio in Q2 2024, its #786 holding.
  • ICA Group Wealth Management first reported a position in Jazz Pharmaceuticals in Q4 2022 and has held it in 6 quarters since.
  • ICA Group Wealth Management's Jazz Pharmaceuticals position peaked at $157 in Q4 2022.
  • 455 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2024.

Based on ICA Group Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.